Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

To determine the prevalence of parvovirus 4 infection and its clinical and sociodemographic correlations in Finland, we used virus-like particle-based serodiagnostic procedures (immunoglobulin [Ig] G, IgM, and IgG avidity) and PCR. We found 2 persons with parvovirus 4 primary infection who had mild or asymptomatic clinical features among hepatitis C virus-infected injection drug users.

Original publication

DOI

10.3201/eid1701.100750

Type

Journal article

Journal

Emerg Infect Dis

Publication Date

01/2011

Volume

17

Pages

79 - 82

Keywords

Antibodies, Viral, DNA, Viral, Finland, HIV Infections, Hepacivirus, Hepatitis C, Humans, Immunoglobulin G, Immunoglobulin M, Parvoviridae Infections, Parvovirus, Polymerase Chain Reaction, Prevalence, Serologic Tests, Substance Abuse, Intravenous